Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
JAMA Intern Med. 2021 Dec 1;181(12):1623-1630. doi: 10.1001/jamainternmed.2021.6227.
JAMA Intern Med. 2021.
PMID: 34724025